awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47148072-A6F00567-E93D-446E-B1F7-8FD5E6DE8A20
Q47148072-A6F00567-E93D-446E-B1F7-8FD5E6DE8A20
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47148072-A6F00567-E93D-446E-B1F7-8FD5E6DE8A20
Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer.
P2860
Q47148072-A6F00567-E93D-446E-B1F7-8FD5E6DE8A20
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47148072-A6F00567-E93D-446E-B1F7-8FD5E6DE8A20
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e02296f029d40e920c511e02b70c7d0f9048be35
P2860
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.